| 1 | [SID26748005] | Active | Potency | 0.0326 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.0326 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID26748005] | Active | Potency | 0.0326 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.0326 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID26748005] | Active | Potency | 0.0326 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.0326 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID26748005] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID26748005] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID26748005] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID26748005] | Active | Potency | 0.3162 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.3162 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 8 | [SID26748005] | Active | Potency | 0.5 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.5 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 9 | [SID26748005] | Active | Potency | 0.5012 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.5012 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 10 | [SID26748005] | Active | Potency | 0.7943 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 11 | [SID26748005] | Active | Potency | 0.7943 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 12 | [SID26748005] | Active | Potency | 0.7943 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 13 | [SID26748005] | Active | Potency | 0.7943 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 14 | [SID26748005] | Active | Potency | 2.5119 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 15 | [SID26748005] | Active | Potency | 2.5119 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 16 | [SID26748005] | Active | Potency | 2.5119 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 17 | [SID26748005] | Active | Potency | 2.5119 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 18 | [SID26748005] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 19 | [SID26748005] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 20 | [SID26748005] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity [AID2786, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity | | AID | 2786 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID26748005] | Active | Potency | 3.1623 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 22 | [SID26748005] | Active | Potency | 3.9811 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 23 | [SID26748005] | Active | Potency | 3.9811 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 24 | [SID26748005] | Active | Potency | 3.9811 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 25 | [SID26748005] | Active | Potency | 3.9811 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 26 | [SID26748005] | Active | Potency | 10 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition [AID2785, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition | | AID | 2785 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 27 | [SID26748005] | Active | Potency | 19.9526 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 28 | [SID26748005] | Active | Potency | 19.9526 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 29 | [SID26748005] | Active | Potency | 19.9526 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 30 | [SID26748005] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID26748005] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID26748005] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 33 | [SID26748005] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 34 | [SID26611714] | Active | | | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen [AID1422, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26611714 | | CID | 6327770 | | Outcome | Active | | BioAssay | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen | | AID | 1422 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 35 | [SID26611714] | Active | | | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen [AID1422, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26611714 | | CID | 6327770 | | Outcome | Active | | BioAssay | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen | | AID | 1422 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 36 | [SID26748005] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 37 | [SID26748005] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26748005 | | CID | 6327770 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 38 | [SID8149315] | Active | | | Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC) [AID1598, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Active | | BioAssay | Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC) | | AID | 1598 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID92124096] | Active | | | A screen for compounds that inhibit replication of Vibrio cholerae chromosome II [AID504770, Type: other] | hypothetical protein VC_A0002 [Vibrio cholerae O1 biovar El Tor str. N16961] [gi:9657380] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 92124096 | | CID | 6327770 | | Outcome | Active | | BioAssay | A screen for compounds that inhibit replication of Vibrio cholerae chromosome II | | AID | 504770 | | BioAssay type | other | | Target | hypothetical protein VC_A0002 [Vibrio cholerae O1 biovar El Tor str. N16961] [gi:9657380] | | PubMed | | | Data Table |  |
|
| 40 | [SID53786509] | Active | | | JHICC rubidium efflux Assay [AID1407, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 53786509 | | CID | 6327770 | | Outcome | Active | | BioAssay | JHICC rubidium efflux Assay | | AID | 1407 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 41 | [SID53786509] | Active | | | JHICC rubidium efflux Assay [AID1407, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 53786509 | | CID | 6327770 | | Outcome | Active | | BioAssay | JHICC rubidium efflux Assay | | AID | 1407 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 42 | [SID8149315] | Unspecified | | | Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) [AID1599, Type: other] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) | | AID | 1599 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID8149315] | Unspecified | | | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) | | AID | 1593 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID8149315] | Unspecified | | | Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) | | AID | 1583 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID8149315] | Unspecified | | | Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) [AID1603, Type: other] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) | | AID | 1603 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID8149315] | Unspecified | | | Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) [AID1604, Type: other] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) | | AID | 1604 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID8149315] | Unspecified | | | Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) [AID1605, Type: other] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) | | AID | 1605 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID8149315] | Unspecified | | | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) | | AID | 1612 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID8149315] | Unspecified | | | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) | | AID | 1613 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID8149315] | Unspecified | | | Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 8149315 | | CID | 6327770 | | Outcome | Unspecified | | BioAssay | Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) | | AID | 1614 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|